share_log

贝瑞基因(000710.SZ):目前并无肝病基因药物产品,亦无肿瘤基因疫苗研发

Berry Genomics (000710.SZ): Currently, there are no genetic drugs for liver diseases, nor are there any research and development of tumor genetic vaccines.

Gelonghui Finance ·  Dec 3 08:10

On December 3, BioMap (000710.SZ) stated on the investor interaction platform that the company currently does not have liver disease genetic drug products, nor does it have research and development of tumor genetic vaccines. The company is dedicated to fully converting gene sequencing technology into clinical applications, focusing on areas such as reproductive health, genetic disease testing, tumor detection, and technology services. The company currently provides sequencing services for some innovative drug companies.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment